ADMA BIOLOGICS INC (ADMA)
US0008991046 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to ADMA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.54. This target is 33.16% above the current price.
ADMA was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ADMA.
In the previous month the buy percentage consensus was at a similar level.
ADMA was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-01 | Mizuho | Maintains | Buy -> Buy |
| 2024-02-29 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-02-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-22 | Mizuho | Maintains | Buy -> Buy |
| 2024-01-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-19 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-11-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-10 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-08-10 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2023-08-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-27 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-03 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-10 | Mizuho | Maintains | Buy |
| 2022-10-13 | Mizuho | Initiate | Buy |
| 2022-07-25 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-11 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2021-11-09 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-10-26 | Raymond James | Maintains | Outperform |
| 2021-08-12 | HC Wainwright & Co. | Maintains | Buy |
| 2021-07-06 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-26 | Raymond James | Maintains | Outperform |